Variant report
Variant | nsv1034584 |
---|---|
Chromosome Location | chr9:9458137-9486282 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113471794 | chr9:9464024-9464025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534594420 | chr9:9464039-9464040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10977782 | chr9:9464056-9464057 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs564569019 | chr9:9464078-9464079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538885590 | chr9:9464084-9464085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557197765 | chr9:9464088-9464089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10977783 | chr9:9464090-9464091 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs536362047 | chr9:9464113-9464114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs117073150 | chr9:9464114-9464115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572829103 | chr9:9464135-9464136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs372967351 | chr9:9464156-9464157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550364923 | chr9:9464181-9464182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs112124550 | chr9:9464199-9464200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569859776 | chr9:9464202-9464203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs112397191 | chr9:9464234-9464235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112636652 | chr9:9464258-9464259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545154752 | chr9:9464370-9464371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs529591133 | chr9:9464379-9464380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147736697 | chr9:9464401-9464402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs10491614 | chr9:9464410-9464411 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs191268073 | chr9:9464450-9464451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561114036 | chr9:9464479-9464480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs62533171 | chr9:9464498-9464499 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs546915570 | chr9:9464507-9464508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141089958 | chr9:9464527-9464528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs369546124 | chr9:9464544-9464545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150278489 | chr9:9464557-9464558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs183759737 | chr9:9464559-9464560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10491613 | chr9:9464561-9464562 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs114695610 | chr9:9464598-9464599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs145813121 | chr9:9464608-9464609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs76466806 | chr9:9464620-9464621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs75466907 | chr9:9464621-9464622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs373497609 | chr9:9464634-9464635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs148992335 | chr9:9464642-9464643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs145309400 | chr9:9464651-9464652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558136374 | chr9:9464672-9464673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577880993 | chr9:9464686-9464687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs137939239 | chr9:9464699-9464700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577296023 | chr9:9464740-9464741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs575832831 | chr9:9464766-9464767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542748804 | chr9:9464808-9464809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561480775 | chr9:9464811-9464812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142321188 | chr9:9464819-9464820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs536862611 | chr9:9464860-9464861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs556708916 | chr9:9464868-9464869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144611302 | chr9:9464888-9464889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs118147120 | chr9:9464912-9464913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs148202198 | chr9:9464914-9464915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs550880887 | chr9:9464932-9464933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Autism | 20531469 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9464000-9465000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr9:9465000-9465800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr9:9465800-9469600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr9:9469600-9469800 | Flanking Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr9:9469800-9470000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr9:9470000-9470200 | Flanking Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr9:9470200-9470400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr9:9478400-9480200 | Enhancers | Fetal Lung | lung |
9 | chr9:9482600-9483800 | Enhancers | Brain Inferior Temporal Lobe | brain |
10 | chr9:9482800-9484800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr9:9483200-9483600 | Enhancers | Brain Hippocampus Middle | brain |
12 | chr9:9483200-9483800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr9:9483800-9489000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
14 | chr9:9484800-9488800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |